Though they are all second hand and no hard documentation, there are several reports that NWBO is selling the treatment in the UK Specials program at a price that aligns with what he asserts.
The problem is that means nothing wrt what it can actually price at in a broad market.
The last official statement on price from NWBO that I am aware of is what you cited.
BTW, I do think that if approved they can get a higher price than the numbers you extrapolate. But we have no hard data here. It is all guesswork. And at the end of the day would be up to NICE.
Market Data 
Markets 
AI
